4/15/2026BioConnect DE Biomanufacturing Training Program Celebrates Second Graduating Class
4/15/2026Viewpoint: Homegrown life science firms score major wins, continued success requires investment
3/20/2026 Novartis to acquire Synnovation Therapeutics’s pan-mutant selective PI3Kα inhibitor program
3/18/2026ARPA-H Grants BioCurie Funds to Build Scalable Gene Therapy Manufacturing Platform
Print Page